FRG Family Wealth Advisors’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

FRG Family Wealth Advisors’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	-$3K	–	131
2019 Q1	$3K	Hold	2	–	–	﹤0.01%	125
2018 Q4	$3K	Hold	2	–	–	﹤0.01%	127
2018 Q3	$6K	Hold	2	–	–	﹤0.01%	142
2018 Q2	$7K	Hold	2	–	–	﹤0.01%	149
2018 Q1	$7K	Buy	+2	New	+$5.93K	﹤0.01%	144

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFG

Nadler Financial Group Deerfield, Illinois $1.18B AUM 22.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

FRG Family Wealth Advisors's TMBR Position: Q2 2019 in Review

FRG Family Wealth Advisors sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 2 shares — an estimated $3K sold.

FRG Family Wealth Advisors first reported a position in TMBR in Q1 2018 and held it in 5 quarters. The position peaked at $7K in Q2 2018. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

FRG Family Wealth Advisors reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
FRG Family Wealth Advisors sold 2 Timber Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
FRG Family Wealth Advisors first reported a position in Timber Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
FRG Family Wealth Advisors's Timber Pharmaceuticals, Inc. position peaked at $7K in Q2 2018.
14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on FRG Family Wealth Advisors's 13F filing for Q2 2019, filed 2 Mar 2022.